Version 2.77

Term Description

Panel for qualitative or quantitative screening for Hepatitis C virus RNA. This panel was created for Meaningful Use 3 as part of a project by the American Medical Association (AMA) to develop three Clinical Quality Measures for Hepatitis C - 1) One-Time Screening for HCV for Patients at Risk, 2) HCV Screening for Active Injection Drug Users, and 3) Appropriate Screening Follow-up for Patients with HCV Infection. This concept may be used by physicians to document that he/she has reviewed the HCV RNA test results performed by an outside lab. When the physician does not know which specific LOINC code to choose when documenting the test and results from the lab report, this more generic LOINC panel code can be used. The HCV RNA screening panel includes all HCV RNA tests used in screening, confirming or monitoring for HCV infection or HCV infection progress, except HCV RNA test that are used to determine therapeutic approaches to management of HCV infection, such as HCV RNA genotyping. In the eMeasure, this LOINC panel and associated LOINC codes will be included in a larger value set for the specific type of screening - HCV RNA Test.
Source: Regenstrief LOINC

Panel Hierarchy

Details for each LOINC in Panel LHC-Forms

LOINC Name R/O/C Cardinality Example UCUM Units
75888-8 HCV RNA screening tests - Meaningful Use set
Indent10676-5 Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification [IU]/mL
Indent11011-4 Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection k[IU]/mL
Indent11259-9 Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
Indent20416-4 Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection {copies}/mL
Indent20571-6 Hepatitis C virus RNA [#/volume] (viral load) in Serum or Plasma by Probe with signal amplification 10*6{viral equivalents}/mL
Indent29609-5 Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with signal amplification [IU]/mL
Indent34703-9 Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 500 IU/mL [IU]/mL
Indent34704-7 Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL [IU]/mL
Indent38180-6 Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by NAA with probe detection {Log_IU}/mL
Indent38998-1 HIV 1+Hepatitis C virus RNA [Presence] in Serum or Plasma from Blood product unit by NAA with probe detection
Indent42003-4 Hepatitis C virus RNA [Log #/volume] (viral load) in Serum or Plasma by Probe with signal amplification {Log_copies}/mL
Indent42617-1 Hepatitis C virus RNA [log units/volume] (viral load) in Serum or Plasma by Probe with signal amplification {Log_IU}/mL
Indent47252-2 Hepatitis C virus RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection {log_copies}/mL
Indent48576-3 Hepatitis C virus RNA [Presence] in Specimen by Probe with signal amplification
Indent49369-2 Hepatitis C virus RNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection {copies}/mL
Indent49370-0 Hepatitis C virus RNA [#/volume] (viral load) in Bone marrow by NAA with probe detection {copies}/mL
Indent49371-8 Hepatitis C virus RNA [#/volume] (viral load) in Tissue by NAA with probe detection {copies}/mL
Indent49372-6 Hepatitis C virus RNA [Log #/volume] (viral load) in Specimen by NAA with probe detection {Log_copies}/mL
Indent49373-4 Hepatitis C virus RNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection {Log_copies}/mL
Indent49374-2 Hepatitis C virus RNA [Log #/volume] (viral load) in Bone marrow by NAA with probe detection {Log_copies}/mL
Indent49375-9 Hepatitis C virus RNA [Log #/volume] (viral load) in Tissue by NAA with probe detection {Log_copies}/mL
Indent49376-7 Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection [IU]/mL
Indent49377-5 Hepatitis C virus RNA [Units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection [IU]/mL
Indent49378-3 Hepatitis C virus RNA [Units/volume] (viral load) in Bone marrow by NAA with probe detection [IU]/mL
Indent49379-1 Hepatitis C virus RNA [Units/volume] (viral load) in Tissue by NAA with probe detection [IU]/mL
Indent49380-9 Hepatitis C virus RNA [#/volume] (viral load) in Specimen by NAA with probe detection {copies}/mL
Indent49603-4 Hepatitis C virus RNA [log units/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection {Log_IU}/mL
Indent49604-2 Hepatitis C virus RNA [log units/volume] (viral load) in Bone marrow by NAA with probe detection {Log_IU}/mL
Indent49605-9 Hepatitis C virus RNA [log units/volume] (viral load) in Specimen by NAA with probe detection {Log_IU}/mL
Indent49608-3 Hepatitis C virus RNA [log units/volume] (viral load) in Tissue by NAA with probe detection {Log_IU}/mL
Indent49758-6 Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 5 iU/mL [IU]/mL
Indent50023-1 Hepatitis C virus RNA panel (viral load) in Serum or Plasma by NAA with probe detection
Indent5010-4 Hepatitis C virus RNA [Presence] in Blood by NAA with probe detection
Indent5011-2 Hepatitis C virus RNA [Presence] in Tissue by NAA with probe detection
Indent5012-0 Hepatitis C virus RNA [Presence] in Specimen by NAA with probe detection
Indent51655-9 Hepatitis C virus RNA [Presence] in Body fluid by NAA with probe detection
Indent53825-6 HIV 1+Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
Indent59052-1 HIV 1+Hepatitis C virus RNA+Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
Indent74856-6 HIV 1 group O RNA+HIV 1 group M RNA+HIV 2 RNA+Hepatitis C virus RNA+Hepatitis B virus DNA [Presence] in Serum or Plasma from Donor by NAA with probe detection

Fully-Specified Name

Component
HCV RNA screening tests - Meaningful Use set
Property
-
Time
Pt
System
^Patient
Scale
-
Method

Additional Names

Short Name
HCV RNA MU Set Patient
Display Name
HCV RNA screening tests - Meaningful Use set
Consumer Name Alpha Get Info
Hepatitis C virus (HCV) RNA Screening Tests - Meaningful Use Set

Basic Attributes

Class
PANEL.MICRO
Type
Laboratory
First Released
Version 2.50
Last Updated
Version 2.58
Order vs. Observation
Both
Panel Type
Convenience group

Language Variants Get Info

Tag Language Translation
es-ES Spanish (Spain) Pruebas de cribado de ARN de HCV de uso conjunto significativo:Propiedades mixtas (sólo paneles):Punto temporal:^paciente:-:
es-MX Spanish (Mexico) Pruebas de detección de ARN del VHC:conjunto de uso significativo:-:Punto temporal:^ Paciente:-
fr-FR French (France) Hépatite C virus ARN tests de dépistage:-:Ponctuel:Patient:-:
it-IT Italian (Italy) Test di screening per HCV RNA - Meaningful Use set:-:Pt:^Paziente:-:
Synonyms: Microbiologia paziente Punto nel tempo (episodio) Set di prescrizione microbiologia
pl-PL Polish (Poland) Badania przesiewowe HCV RNA - optymalny zestaw:-:punkt w czasie:^pacjent:-:
zh-CN Chinese (China) HCV RNA 筛查试验 - 有效利用集:-:时间点:^患者:-:
Synonyms: Asympt HCV RNA(核糖核酸) 筛查(筛选、过筛、筛检)试验(检验项目、化验项目、测试、化验、检测) - 有效利用(Meaningful Use、MU、有效实用)集(集合);Hepatitis C;HCV;丙型肝炎病毒;C 型肝炎病毒;丙肝病毒 SCN 医嘱套餐 医嘱套餐类 医嘱套餐组 医嘱组 医嘱组.微生物学;实验室组套(组合、医嘱组、套餐、套餐医嘱、医嘱套餐、组合申请、组合项目)类.微生物学试验;医嘱组.微生物学试验;医嘱组类.微生物学;医嘱组类.微生物学试验;实验室医嘱组类.微生物学;微生物学医嘱组;微生物学医嘱组类 医嘱组合 医嘱组合类 医嘱组套 医嘱组套类 医嘱组类 医疗服务对象;客户;病人;病患;病号;超系统 - 病人 多重;多重型;多重标尺类型;多重精度类型 套餐 套餐医嘱 套餐医嘱组 套餐医嘱组类 实验室医嘱套餐 实验室医嘱套餐类 实验室医嘱组 实验室医嘱组合类 实验室医嘱组套 实验室医嘱组套类 实验室套餐医嘱组 实验室套餐医嘱组类 实验室检验项目医嘱组合类 实验室检验项目组合类 微生物学;微生物学试验;微生物学试验(培养、DNA、抗原及抗体) 无症状 无症状(Asymptomatic,Asympt) 无症状的 无症状筛查 时刻;随机;随意;瞬间 普查 普查试验 核糖核酸;Ribonucleic acid 检验医嘱组合类 检验项目医嘱组合类 检验项目组合类 筛分 筛分试验 筛查(Screening,SCN) 筛查试验 筛选 筛选试验 组 组合 组合医嘱 组合类 组套

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=75888-8
Questionnaire definition
https://fhir.loinc.org/Questionnaire/?url=http://loinc.org/q/75888-8